Total Payments
$9,536
2024 Payments
$4,079
Companies
20
Transactions
83
Medicare Patients
10,069
Medicare Billing
$10.4M
Payment Breakdown by Category
Food & Beverage$7,246 (76.0%)
Consulting$2,290 (24.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,246 | 82 | 76.0% |
| Consulting Fee | $2,290 | 1 | 24.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $3,329 | 12 | $0 (2024) |
| Alimera Sciences, Inc. | $891.07 | 11 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $877.68 | 12 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $850.57 | 9 | $0 (2024) |
| Alcon Vision LLC | $763.53 | 7 | $0 (2024) |
| Alcon Laboratories Inc | $433.74 | 4 | $0 (2018) |
| Astellas Pharma US Inc | $393.09 | 4 | $0 (2024) |
| Carl Zeiss Meditec USA, Inc. | $308.47 | 3 | $0 (2024) |
| Allergan, Inc. | $273.38 | 4 | $0 (2021) |
| Coherus Biosciences Inc. | $228.98 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,079 | 23 | Genentech USA, Inc. ($2,623) |
| 2023 | $1,570 | 16 | Alcon Vision LLC ($380.79) |
| 2022 | $1,068 | 12 | Genentech USA, Inc. ($278.42) |
| 2021 | $406.82 | 4 | Regeneron Healthcare Solutions, Inc. ($138.19) |
| 2020 | $99.93 | 1 | Regeneron Healthcare Solutions, Inc. ($99.93) |
| 2019 | $843.60 | 10 | Regeneron Healthcare Solutions, Inc. ($156.78) |
| 2018 | $1,000 | 12 | Alimera Sciences, Inc. ($338.47) |
| 2017 | $468.06 | 5 | Alimera Sciences, Inc. ($253.13) |
All Payment Transactions
83 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Sandoz Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $68.67 | General |
| Category: Ophthalmology | ||||||
| 11/19/2024 | Alcon Vision LLC | Constellation (Device) | Food and Beverage | In-kind items and services | $98.67 | General |
| Category: Ophthalmology | ||||||
| 11/12/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $113.00 | General |
| Category: Ophthalmology | ||||||
| 10/23/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological), EYLEA | Food and Beverage | In-kind items and services | $128.14 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/19/2024 | US Oncology Corporate, Inc. | — | Food and Beverage | Cash or cash equivalent | $69.62 | General |
| 10/19/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological), EYLEA | Food and Beverage | In-kind items and services | $37.29 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/18/2024 | Genentech USA, Inc. | Vabysmo (Drug), Susvimo | Food and Beverage | In-kind items and services | $147.81 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/17/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/24/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Consulting Fee | Cash or cash equivalent | $2,290.00 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/22/2024 | Alimera Sciences, Inc. | ILUVIEN (Drug), YUTIQ | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: treatment of diabetic macular edema in patients who have been previously treated with corticosteroid | ||||||
| 08/20/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $26.34 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/30/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA (Biological), EYLEA HD | Food and Beverage | In-kind items and services | $55.78 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/25/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $27.04 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/10/2024 | Alcon Vision LLC | Constellation (Device) | Food and Beverage | In-kind items and services | $120.68 | General |
| Category: Ophthalmology | ||||||
| 05/30/2024 | Carl Zeiss Meditec USA, Inc. | VERACITY SURGICAL (Device) | Food and Beverage | In-kind items and services | $159.59 | General |
| Category: Eye Care Data Management | ||||||
| 05/29/2024 | Carl Zeiss Meditec USA, Inc. | — | Food and Beverage | In-kind items and services | $41.27 | General |
| 04/30/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $69.06 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 04/16/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $34.11 | General |
| Category: Immunology and Ophthalmology | ||||||
| 03/27/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $69.74 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/26/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/27/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $109.36 | General |
| Category: Ophthalmology | ||||||
| 02/13/2024 | Genentech, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: Immunology and Ophthalmology | ||||||
| 01/17/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $116.58 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/13/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/05/2023 | Alcon Vision LLC | Constellation (Device) | Food and Beverage | In-kind items and services | $127.28 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 2,782 | 19,897 | $7.0M | $2.9M |
| 2022 | 13 | 2,474 | 11,450 | $6.6M | $2.6M |
| 2021 | 14 | 2,321 | 9,967 | $5.9M | $2.3M |
| 2020 | 14 | 2,492 | 9,226 | $6.7M | $2.6M |
Total Patients
10,069
Total Services
50,540
Medicare Billing
$10.4M
Procedure Codes
57
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 125 | 1,280 | $2.3M | $871,853 | 38.5% |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | Office | 2023 | 181 | 3,143 | $1.2M | $681,076 | 59.0% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 198 | 3,128 | $1.7M | $579,075 | 33.7% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 584 | 1,961 | $402,005 | $169,057 | 42.1% |
| 67028 | Injection of drug into eye | Office | 2023 | 362 | 1,627 | $514,290 | $162,814 | 31.7% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 12 | 5,160 | $283,800 | $149,869 | 52.8% |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | Office | 2023 | 21 | 497 | $99,897 | $59,819 | 59.9% |
| 92250 | Photography of the retina | Office | 2023 | 667 | 2,172 | $278,528 | $56,363 | 20.2% |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 2023 | 13 | 252 | $90,720 | $39,905 | 44.0% |
| J3490 | Unclassified drugs | Office | 2023 | 12 | 18 | $58,780 | $28,943 | 49.2% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 268 | 278 | $63,764 | $28,042 | 44.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 186 | 186 | $52,638 | $22,047 | 41.9% |
| 67041 | Removal of membrane of retina | Facility | 2023 | 14 | 14 | $36,400 | $11,500 | 31.6% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 33 | 64 | $9,968 | $5,798 | 58.2% |
| 92134 | Imaging of retina | Office | 2023 | 79 | 82 | $6,478 | $2,289 | 35.3% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 27 | 35 | $5,740 | $1,203 | 21.0% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 189 | 1,823 | $3.2M | $1.3M | 40.5% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 204 | 3,976 | $2.2M | $874,423 | 40.0% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 587 | 1,703 | $349,115 | $145,554 | 41.7% |
| 67028 | Injection of drug into eye | Office | 2022 | 374 | 1,395 | $435,330 | $136,256 | 31.3% |
| 92250 | Photography of the retina | Office | 2022 | 667 | 1,887 | $241,536 | $48,317 | 20.0% |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 2022 | 14 | 175 | $63,000 | $27,564 | 43.8% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2022 | 207 | 212 | $48,548 | $19,222 | 39.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 133 | 133 | $37,639 | $15,481 | 41.1% |
| J7999 | Compounded drug, not otherwise classified | Office | 2022 | 29 | 55 | $6,720 | $3,886 | 57.8% |
About Dr. Daniel Kasuga, MD
Dr. Daniel Kasuga, MD is a Retina Specialist healthcare provider based in El Paso, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/25/2010. The National Provider Identifier (NPI) number assigned to this provider is 1568786176.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Kasuga, MD has received a total of $9,536 in payments from pharmaceutical and medical device companies, with $4,079 received in 2024. These payments were reported across 83 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($7,246).
As a Medicare-enrolled provider, Kasuga has provided services to 10,069 Medicare beneficiaries, totaling 50,540 services with total Medicare billing of $10.4M. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Ad
Practice Information
- Specialty Retina Specialist
- Other Specialties Ophthalmology, Retina Specialist
- Location El Paso, TX
- Active Since 03/25/2010
- Last Updated 06/17/2020
- Taxonomy Code 207WX0107X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1568786176
Products in Payments
- Vabysmo (Drug) $2,876
- Constellation (Device) $1,197
- EYLEA (Biological) $1,098
- Lucentis (Biological) $449.32
- EYLEA HD (Biological) $422.48
- Cimerli (Biological) $297.65
- OZURDEX (Drug) $273.38
- Iluvien (Drug) $253.13
- ILUVIEN (Drug) $230.41
- Izervay (Drug) $222.36
- EYLEA AFLIBERCEPT INJECTION (Biological) $207.31
- VERACITY SURGICAL (Device) $159.59
- YUTIQ (Drug) $143.00
- DEXYCU (Drug) $130.67
- Syfovre (Drug) $123.47
- VISUDYNE (Drug) $111.05
- Retina Workplace (Device) $107.61
- BROLUCIZUMAB (Drug) $106.31
- BEOVU (Drug) $100.40
- LUXTURNA (Biological) $99.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.